This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Joerg Matthias Sedelmeier: Innovator in Chemical Synthesis
Introduction
Joerg Matthias Sedelmeier is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of chemical synthesis, particularly in the development of novel processes for creating complex compounds. His work is characterized by a focus on innovative methodologies that enhance the efficiency and effectiveness of chemical reactions.
Latest Patents
One of Sedelmeier's key patents is titled "Process for preparing N-(4-cyclohexyl-3-trifluoromethyl-benzyloxy)-acetimidic acid ethyl ester." This invention relates to novel processes for synthesizing N-(4-cyclohexyl-3-trifluoromethyl-benzyloxy)-acetimidic acid ethyl ester and other intermediates used in such processes. He holds 1 patent in this area, showcasing his expertise and innovative approach to chemical synthesis.
Career Highlights
Sedelmeier is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other talented professionals in the field, further advancing the company's research and development efforts. His contributions have been instrumental in driving innovation within the organization.
Collaborations
Throughout his career, Sedelmeier has worked alongside esteemed colleagues such as Fabrice Gallou and Caspar Vogel. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new chemical processes.
Conclusion
Joerg Matthias Sedelmeier is a distinguished inventor whose work in chemical synthesis has made a significant impact in the field. His innovative processes and collaborations with other experts continue to drive advancements in healthcare and chemical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
